USNA vs. PBH, HLF, NUS, NATR, MED, VERU, EL, IPAR, TLRY, and CRON
Should you be buying USANA Health Sciences stock or one of its competitors? The main competitors of USANA Health Sciences include Prestige Consumer Healthcare (PBH), Herbalife (HLF), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Veru (VERU), Estée Lauder Companies (EL), Inter Parfums (IPAR), Tilray (TLRY), and Cronos Group (CRON).
Prestige Consumer Healthcare (NYSE:PBH) and USANA Health Sciences (NYSE:USNA) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations, community ranking, dividends and media sentiment.
Prestige Consumer Healthcare has higher revenue and earnings than USANA Health Sciences. USANA Health Sciences is trading at a lower price-to-earnings ratio than Prestige Consumer Healthcare, indicating that it is currently the more affordable of the two stocks.
Prestige Consumer Healthcare received 90 more outperform votes than USANA Health Sciences when rated by MarketBeat users. Likewise, 70.70% of users gave Prestige Consumer Healthcare an outperform vote while only 60.68% of users gave USANA Health Sciences an outperform vote.
Prestige Consumer Healthcare has a beta of 0.53, indicating that its stock price is 47% less volatile than the S&P 500. Comparatively, USANA Health Sciences has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500.
Prestige Consumer Healthcare has a net margin of 18.60% compared to Prestige Consumer Healthcare's net margin of 6.88%. USANA Health Sciences' return on equity of 13.48% beat Prestige Consumer Healthcare's return on equity.
100.0% of Prestige Consumer Healthcare shares are held by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are held by institutional investors. 1.6% of Prestige Consumer Healthcare shares are held by insiders. Comparatively, 0.3% of USANA Health Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
In the previous week, USANA Health Sciences had 7 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 9 mentions for USANA Health Sciences and 2 mentions for Prestige Consumer Healthcare. Prestige Consumer Healthcare's average media sentiment score of 0.70 beat USANA Health Sciences' score of 0.45 indicating that USANA Health Sciences is being referred to more favorably in the news media.
Prestige Consumer Healthcare presently has a consensus price target of $91.25, suggesting a potential upside of 44.43%. USANA Health Sciences has a consensus price target of $46.00, suggesting a potential downside of 1.86%. Given USANA Health Sciences' higher possible upside, equities analysts plainly believe Prestige Consumer Healthcare is more favorable than USANA Health Sciences.
Summary
Prestige Consumer Healthcare beats USANA Health Sciences on 13 of the 17 factors compared between the two stocks.
Get USANA Health Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for USNA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding USNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
USANA Health Sciences Competitors List
Related Companies and Tools
